Active Cancer Biomarkers Grants

PI Name Organization - Companysort descending Title Major Program / Research Group FOA
Chung, Fung-Lung Georgetown University gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention PAR-15-307: Translational Studies on Adducts for Cancer Risk Identification and Prevention
Riegel, Anna Tate Georgetown University (PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer RFA-CA-15-008: Research Answers to NCI's Provocative Questions
Lin, Jia-Ren Harvard Medical School Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images PAR-21-285: NCI Research Specialist (Laboratory-based Scientist) Award
Schabath, Matthew B H. Lee Moffitt Cancer Ctr & Res Inst Moffitt Imaging Biomarker VAlidation Center Early Detection Research Network, EDRN Clinical Validation Center RFA-CA-14-015: The Early Detection Research Network: Clinical Validation Centers
Permuth, Jennifer B H. Lee Moffitt Cancer Ctr & Res Inst Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology PA-18-484: NIH Research Project Grant
Hirsch, Fred R Icahn School Of Medicine At Mount Sinai Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses COVID Serology RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence
Brennan, Paul Joseph International Agency For Res On Cancer PROMINENT - IARC
Almonte, Maribel International Agency For Res On Cancer Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries RFA-CA-15-001: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UH2/UH3)
Wei, Chia-Lin Jackson Laboratory Advancing Ultra Long-read Sequencing and Chromatin Interaction Analyses for Chromosomal and Extrachromosomal Structural Variation Characterization in Cancer RFA-CA-19-020: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Bettegowda, Chetan Johns Hopkins University Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid PA-16-160: NIH Research Project Grant
Umbricht, Christopher B Johns Hopkins University Discovery and validation of early molecular breast cancer risk markers in benign breast disease PA-16-160: NIH Research Project Grant
Wang, Tza-Huei Johns Hopkins University Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women PA-20-185: NIH Research Project Grant
Chan, Daniel Wanyui Johns Hopkins University Clinical and Analytical Validation of Cancer Biomarkers Early Detection Research Network, EDRN Biomarker Reference Lab RFA-CA-14-016: The Early Detection Research Network: Biomarker Reference Laboratories
Meltzer, Stephen J Johns Hopkins University Facile screening for esophageal cancer in LMICs RFA-CA-15-024: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UG3/UH3)
Papadopoulos, Nickolas Johns Hopkins University Earlier Detection of Cancers using Non-Plasma Based Liquid Biopsies Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment

Pages